_ShalinShah (@_ShalinShah) header
_ShalinShah (@_ShalinShah) profile picture

CEO @MariusPharma, Men’s Health, Hormones, Longevity

Joined October 2019
Photo by _ShalinShah (@_ShalinShah)Photo by _ShalinShah (@_ShalinShah)Photo by _ShalinShah (@_ShalinShah)Photo by _ShalinShah (@_ShalinShah)
We surveyed 1,003 American men aged 40–65 about their health. 65% have never had their testosterone tested. Not once. Meanwhile 75% reported a symptom of low T in the past year. That gap is the whole problem. 🧵
1
3
1
5
372
1/ Same FDA, two standards. Peptides with no Phase 3 human efficacy or safety trials just got a compounding path. Testosterone for women, studied in randomized trials and approved in Australia and the UK, is still waiting in the US.
1
2
84
4/ Now apply it to women's testosterone. No FDA-approved product in the US. A 2019 global consensus from medical societies. Approved in Australia and the UK. Women are using compounders and workarounds right now.
1
1
11
5/ I'm not asking FDA to lower the bar. I'm asking why the bar is so different. If the grey market justifies pragmatism for peptides, it should justify at least as much for a hormone every woman already makes.
4
For the last few weeks, the military and medical communities have been buzzing about a recent Department of War memo. But they have not been buzzing enough. On September 17, the Defense Health Agency released clinical guidelines for the Pentagon's new testosterone screening of male service members. My husband, Shane, and I are two of the four physicians who wrote these guidelines, along with Dr. Larry Lipshultz and Dr. Mohit Khera. Many media outlets ran with a polarized version of the story, implying that the Pentagon is handing out testosterone to build bigger, more aggressive soldiers. The real story is much narrower, highly conventional medically, and long overdue. I have been treating operators for 15 years, and Shane served ten years on active duty as a Navy SEAL and combat medic. I started treating our warfighters because they were not getting the care that they needed, and they were suffering. Until recently, military medicine did not consistently test for this, and the men who took testosterone on their own for therapeutic reasons were treated as steroid abusers. Now, the annual health assessment includes a symptom and risk-factor screen for every male service member 30 and older. Evaluation and treatment are his choice. We are not trying to create “super soldiers.” They are already super themselves, and they are going to push through regardless. We are treating diagnosed deficiencies so that our service members can finally get the care they need. If you would like to learn more, I recently published a podcast episode with my dear friend and incredible advocate Tim Parlatore (this was one of my favorite interviews of all time). Without him these guidelines would not be possible. He is a special advisor to the Secretary of War who helped advocate for these guidelines, and one of the first people to speak publicly about the reasoning behind them. Full episode: youtube.com/watch?v=7U3J1Dk6…
2
2
1
33
3,047
_ShalinShah retweeted
New Testosterone Therapy Screening & Treatment Guidelines released. Congratulations to all of those who worked on this. This is going to be a great thing and will help many. Female TTh is next! #urology #military #BCMUrology #testosterone #veterans #DoW #menshealth @DeptofWar @SMSNA_ORG @AmerUrological @bcm_urology
2
11
1,768
Last week the FDA requested updates to testosterone therapy labeling — a turning point for evidence-based men’s health, and the second major labeling action in 16 months.
2
1
55
Marius has spent years building the scientific foundation for exactly this shift. Full statement in the replies.
1
15
_ShalinShah retweeted
⭐️ Important label changes for testosterone 💊- no major cardio AEs, approved for age-related decline, only restricted to metastatic prostate cancer, no concerns for BPH. ✅ We previously showed safety in men on Active Surveillance receiving TTh. academic.oup.com/jsm/article…
1
4
9
2,836